Diskussionsleiter: T. Eschenhagen (Hamburg), L. H. Lehmann (Heidelberg)
| (P515) | Epigenetic inhibitors inhibit part of the hypertrophy-associated transcriptome in embryonic stem cell-derived cardiac myocytes | |
| V. Ngo, L. Hein (Freiburg im Breisgau) | ||
| (P516) | MiR-132 inhibition synchronizes microvessel/myocyte growth and converts pathologic to physiologic hypertrophy in pigs | |
| A. Bähr, K. Klett, R. Hinkel, S. Batkai, R. Kozlik-Feldmann, F. Freudental, T. Thum, C. Kupatt (München, Göttingen, Hannover, Hamburg; La Paz, BO) | ||
| (P517) | Circular RNAs in der Calcineurin-vermittelteten kardialen Hypertrophie | |
| K. C. O.-H. Kühl, F. Laurien, S. Hille, F. Dierck, C. Kuhn, M. Eden, P. Rosenstiel, O. J. Müller, N. Frey (Kiel) | ||
| (P518) | N6 adenosine methylation (m6A) of RNA regulates transcriptional plasticity during progression of heart failure | |
| E. Buchholz, T. Berulava, V. Elerdashvili, T. Pena, R. Islam, D. Lbik, B. A. Mohamed, A. Renner, D. von Lewinski, M. Sacherer, K. Sloan, M. Bohnsack, G. Jain, V. Capece, N. Cleve, S. Burkhardt, G. Hasenfuß, A. Fischer, K. Toischer (Göttingen, Bad Oeynhausen; Graz, AT; Basel, CH) | ||
| (P519) | The targetome of miR-21 in defined cardiac cell fractions in the mammalian heart in vivo | |
| C. Beck, D. Ramanujam, J. Kerler, A. P. Schön, S. Engelhardt (München) | ||
| (P520) | Circ24 knockdown induces cardiac hypertrophy | |
| L. Santer, C. Bär, J. Viereck, K. Xiao, T. Thum (Hannover) | ||
| (P521) | Circulating Pro-apoptotic MicroRNA-122 as a Prognostic Biomarker in Patients after TAVR and its Role in Microvesicle-Mediated Intercellular Communication | |
| X. xu, M. R. Hosen, P. R. Goody, S. T. Niepmann, J.-M. Sinning, G. Nickenig, N. Werner, F. Jansen (Bonn) | ||
| (P522) | OH-Tamoxifen does not deteriorate cardiac function in cardiomyocyte-specific MerCreMer transgenic mice | |
| A. Heinen, S. Gödecke, U. Flögel, A. Gödecke (Düsseldorf) |